Medtronic Invades Dialysis Market With Bellco Buy
This article was originally published in Clinica
Executive Summary
Medtronic PLC is expanding its presence in the end-stage renal disease device market with the acquisition of hemodialysis company Bellco Health Corp.
You may also be interested in...
FDA Clears Medtronic’s CRRT System For Pediatric Kidney Disease
The de novo clearance makes the Carpediem system the first commercially available system indicated for continuous renal replacement therapy in pediatric patients.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.